Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001837767 | SCV000284757 | benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genomic Diagnostic Laboratory, |
RCV000239211 | SCV000296911 | benign | Hypercholesterolemia, familial, 1 | 2015-07-29 | criteria provided, single submitter | clinical testing | |
Cardiovascular Research Group, |
RCV000239211 | SCV000322859 | uncertain significance | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | research | 0/190 non-FH alleles |
Illumina Laboratory Services, |
RCV001094759 | SCV000426961 | likely benign | Hypercholesterolemia, autosomal dominant, type B | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Illumina Laboratory Services, |
RCV000293206 | SCV000426962 | uncertain significance | Familial hypobetalipoproteinemia 1 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Gene |
RCV000845395 | SCV000521121 | likely benign | not provided | 2020-07-28 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function This variant is associated with the following publications: (PMID: 30270084, 26020417, 21502677, 27153395, 24503134) |
Laboratory for Molecular Medicine, |
RCV000427612 | SCV000538307 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: ExAC: 0.7% (84/11556) Latino chromosomes |
Color Diagnostics, |
RCV000239211 | SCV000687192 | likely benign | Hypercholesterolemia, familial, 1 | 2017-07-10 | criteria provided, single submitter | clinical testing | |
Robarts Research Institute, |
RCV000239211 | SCV000782796 | uncertain significance | Hypercholesterolemia, familial, 1 | 2018-01-02 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000845395 | SCV000987458 | likely benign | not provided | criteria provided, single submitter | clinical testing | ||
Ce |
RCV000845395 | SCV001156206 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | APOB: BP4, BS2 |
Ambry Genetics | RCV002450669 | SCV002613536 | likely benign | Cardiovascular phenotype | 2018-08-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000845395 | SCV004220782 | likely benign | not provided | 2023-08-10 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003929938 | SCV004743498 | likely benign | APOB-related condition | 2020-10-02 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Laboratory of Genetics and Molecular Cardiology, |
RCV000239211 | SCV000588457 | likely pathogenic | Hypercholesterolemia, familial, 1 | 2016-03-01 | flagged submission | research |